HSPG2 and Insulin resistance: This insulin-resistance state was improved by PLC treatment since the animals receiving this carnitine derivate significantly reduced plasmatic insulin and HOMAIR (P<0.001 vs vehicle-HF, Table 2) and fasting glucose was not significantly different to vehicle-ST.